Sigþór Sigmarsson
Director @ Novator
London, United Kingdom
Sigþór Sigmarsson is a seed investor at Novator in London focused on Software and Health Care. Sigþór Sigmarsson is Finance director at Novato. He attended Háskóli Íslands.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 25%
Last updated:
For AI agents: llms.txt
Industries Sigþór Sigmarsson invests in
Stages Sigþór Sigmarsson invests in
Countries Sigþór Sigmarsson invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $400k–$1.8M
Investment Focus
Industry
- Software 2 (50%)
- Health Care 2 (50%)
- Banking 1 (25%)
- FinTech 1 (25%)
- Medical 1 (25%)
Stage
- Seed 2 (50%)
- Series D 1 (25%)
- Venture - Series Unknown 1 (25%)
Country
- Iceland 3 (75%)
- United Kingdom 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Meniga
|
Meniga is a digital banking platform that helps banks, businesses, and individuals manage their financial data. Its product offering includes data aggregation, personal and business finance management, cashback rewards, and transaction-based carbon insights.They are a team of coders, designers, salespeople, and data scientists who get excitedabout shaping the future of financial technology. They work with complicated solutions that operate across channels, are modular, and customizable for every client. If you love big data, predictive models, analytics, operational benchmarking, and getting the job done they’d like to hear from you. | $16.3M / Series D / Dec 13, 2023 | |
Genis
|
GENIS is a biotechnology company headquartered in Siglufjörður, Iceland. They strive to discover, develop and commercialize novel and life-changing products, supplements and medical devices derived from crustacean exoskeletons. The GENIS team has been developing cutting-edge research on the production of chitin, chitosan, and short chain chitosanfor two decades. Their mission is to leverage this accumulated body of world-class scientific research with the intent of providing life-altering benefits for individuals. | $17M / Venture - Series Unknown / Dec 18, 2022 | |
Treble
|
Treble develops advanced acoustic simulation and spatial audio technology that enables engineers and researchers to model, analyze, and optimize sound in both physical and virtual environments.The company provides a cloud based platform that combines wave based acoustic simulation with scalable computing to deliver high fidelity, physicallyaccurate sound modeling. Treble’s technology supports applications across industries including architecture and the built environment, robotics, automotive, consumer electronics, gaming, XR, and audio AI, enabling virtual prototyping, synthetic audio data generation, and faster development of next generation audio systems. | $1.8M / Seed / Oct 20, 2021 | |
3Z Pharmaceuticals
|
3Z Pharmaceuticals provides research services intended to provide drug development services. It offers drug screening on sleep and epilepsy assays that helps in the development of drugs used to treat neurological disorders, enabling patients to get multiple drug efficacy and toxicity assays.Karl Karlsson and Haraldur Thorsteinsson founded 3ZPharmaceuticals in 2008. It based their company on their research on the sleeping patterns of the zebrafish at the Reykjavik University Neurolab in 2006. | $400K / Seed / Jul 05, 2016 |
Co-Investors
About Novator
Novator is an alternative investment firm founded and led by the international investor and entrepreneur Thor Bjorgolfsson.Novator's investment portfolio is focused around following sectors: Telecommunications, Pharmaceuticals, IT and Renewable Energy. In addition, Novator operates a Private Equity Fund and a Credit Opportunities Fund.Novator focuses on developing strong management teams in each of its portfolio companies. While granting them the autonomy to create value, Novator maintains a supervisory role, principally through representation on the Boards of its investee companies. Novator differentiates itself from many other private equity companies in concentrating on complex situations, either by virtue of their structure or their cross-border nature. To create value, Novator undertakes the restructuring or "de-risking" of investment opportunities through re-financing, combining acquired assets with existing businesses, through sale to strategic or financial buyers, or through flotation. Novator's investment portfolio is focused around four main sectors:Telecommunications, Pharmaceuticals, IT and Renewable Energy.
Novator Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Andri Sveinsson
Partner & CFO
|
|||
Anna-Kreeta Rantamaa-Hiltunen
Director
|
|||
Birgir Ragnarsson
Managing Partner
|
|||
Chiehmi Chan
Partner
|
|||
Hasan Qureshi
Founder
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Sigþór Sigmarsson invest in?
Sigþór Sigmarsson invests primarily in Software, Health Care and Banking startups, most often at Seed and Series D stage. Most of the 4 investments tracked by Shizune back companies in Iceland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Sigþór Sigmarsson's check size?
Sigþór Sigmarsson typically joins rounds of $400k–$1.8M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Sigþór Sigmarsson participates in.
How do I contact Sigþór Sigmarsson?
Public channels for Sigþór Sigmarsson include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Sigþór Sigmarsson last invest?
The most recent investment recorded for Sigþór Sigmarsson closed in Dec 2023. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
